Clinical Trials Directory

Trials / Terminated

TerminatedNCT01947036

T and B Cell Responses in Autoimmune Diseases

T and B Cell Responses Across Autoimmune Diseases

Status
Terminated
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
8 Years – 60 Years
Healthy volunteers
Accepted

Summary

The study aims to establish whether defects in immune cell function are shared across multiple autoimmune diseases and whether those problems match to similar genes in the cells.

Detailed description

This is a non-randomized, multi-center clinical research study. Subjects who are healthy or have a confirmed or suspected diagnosis of type 1diabetes, multiple sclerosis, psoriasis, Crohn's disease, or rheumatoid arthritis will be asked to donate a blood sample. No follow-ups are planned. Investigators will: * evaluate immune cells from subjects enrolled in this study and match the differences to types of immune cells known to cause autoimmune diseases * investigate a particular disease pathway: the IL23R signaling cascade.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2013-09-20
Last updated
2016-10-26

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01947036. Inclusion in this directory is not an endorsement.

T and B Cell Responses in Autoimmune Diseases (NCT01947036) · Clinical Trials Directory